The place of gliclazide MR in the evolving type 2 diabetes landscape: A comparison with other sulfonylureas and newer oral antihyperglycemic agents
Colagiuri S et al. Diabetes Res Clin Prac 2018. doi: 10.1016/j.diabres.2018.05.028
Please follow the link below to view this article in full on a third-party website. Note that a subscription or payment may be required.